Search

Compugen Ltd

Uždarymo kaina

2.82 -1.74

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.79

Max

2.93

Pagrindiniai rodikliai

By Trading Economics

Pajamos

663K

-7M

Pardavimai

426K

2.6M

P/E

Sektoriaus vid.

6.816

57.366

Pelnas, tenkantis vienai akcijai

-0.07

Pelno marža

-269.254

Darbuotojai

75

EBITDA

665K

-7M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+74.22% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-09

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

20M

245M

Ankstesnė atidarymo kaina

4.56

Ankstesnė uždarymo kaina

2.82

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-26 23:56; UTC

Fluence Energy Inc shares are higher in after-market trading. Broader market context includes recent PCE price index data indicating ongoing inflationary pressures.

2026-08-26 23:56; UTC

Correlated Moves
Social Media

Tesla shares are trading higher in after-market hours, supported by increased institutional holdings from major investors and a broader market uptick.

2026-08-26 23:56; UTC

Shares of Stanley Black & Decker Inc rose modestly in after-market trading, settling at a cumulative return of 0.33% since Wednesday's close.

2026-08-26 23:56; UTC

Shares of Synchrony Financial are lower in after-market trading, moving from an early high to a low during the session.

2026-08-26 23:56; UTC

RTX Corp. shares are trading lower in after-market hours, with significant volatility noted since Wednesday's close and prices below the 20-day moving average.

2026-08-26 23:56; UTC

Macro Event

EUR/AUD trades lower as Australia's July inflation rate declines to 3.5%, exceeding expectations. The currency pair remains near the lower end of its one-month range.

2026-08-26 23:56; UTC

Ralph Lauren Corp shares are lower in after-market hours, continuing a trend from regular trading. The stock remains below its 20-day moving average.

2026-08-26 23:56; UTC

News

Constellation Brands reported first-quarter results that beat expectations, driven by beer sales. The company also reaffirmed EPS guidance and plans a $100 million investment.

2026-08-26 23:56; UTC

Cheniere Energy shares are trading lower in after-market hours. No specific news was identified to explain this price movement.

2026-08-26 23:52; UTC

AT&T Inc shares are lower in after-market hours with no specific news identified. Broader market data on rising consumer prices may influence investor sentiment.

2026-08-26 23:52; UTC

MARA Holdings Inc. shares are higher in after-market hours, supported by robust economic data and easing crude oil prices, reflecting a positive market trend.

2026-08-26 23:52; UTC

Correlated Moves

The SGD/CHF is trading higher, supported by a recent rise in USD/CHF. It remains near the upper end of its one-month trading range.

2026-08-26 23:52; UTC

The Swiss franc is trading lower against the South African rand during Wednesday's session, remaining near the lower end of its one-month range.

2026-08-26 23:51; UTC

The Nikkei 225 Index is trading higher in after-market hours, continuing a trend of upward movement following Wednesday's close.

2026-08-26 23:51; UTC

Ladder Capital Corp shares are higher in after-market trading, moving up from earlier lows and trading above its 20-day moving average. No specific news identified.

2026-08-26 23:51; UTC

Correlated Moves

Alpha and Omega Semiconductor rises in after-hours trading, recovering from an earlier dip. The stock advanced sharply since Wednesday's close, tracking semiconductor sector gains.

2026-08-26 23:51; UTC

Correlated Moves

PagerDuty Inc. shares are higher in after-market hours, driven by strong overall market momentum and Salesforce Inc.'s significant gain. Positive economic data supports this trend.

2026-08-26 23:51; UTC

Cabaletta Bio Inc shares are lower in after-market trading, following a decline earlier in the session. No specific news was identified to explain the movement.

2026-08-26 23:51; UTC

JetBlue Airways Corp shares are higher in after-market trading, reflecting broader market gains amid positive economic data on consumer prices and durable goods orders.

2026-08-26 23:51; UTC

Community Financial System Inc shares are higher in after-market hours, recovering from earlier lows. The stock remains below its 20-day moving average.

2026-08-26 23:51; UTC

Beam Therapeutics Inc shares are higher in after-market hours, reflecting a broadly positive market trend. The stock is near the upper end of its one-month range.

2026-08-26 23:51; UTC

Arbor Realty Trust is trading higher in after-market hours, advancing from Wednesday's close. Shares earlier pulled back but remain above the prior close.

2026-08-26 23:51; UTC

Yelp Inc shares are higher in after-market trading, recovering from an earlier dip. The stock remains below its 20-day moving average.

2026-08-26 23:51; UTC

PENN Entertainment Inc. shares rose in after-market trading, gaining modestly since Wednesday's close despite remaining below its 20-day moving average.

2026-08-26 23:51; UTC

U.S. markets gain momentum as inflation data reveals slight consumer price rise, while UK car production declines and copper prices surge amid strong demand.

2026-08-26 23:51; UTC

U.S. equity indices rise amid positive global sentiment and inflation data, while investors await Nvidia earnings and navigate geopolitical tensions affecting oil prices.

2026-08-26 23:51; UTC

Asia equity markets rise on falling crude oil prices and tech stock gains, while caution prevails ahead of U.S. inflation data and Fed Chair's speech.

2026-08-26 23:51; UTC

Mixed trading in European equities as easing inflation concerns clash with rising energy prices and UK economic woes.

2026-08-26 23:51; UTC

Brazil's Q2 GDP Growth Rate Expected to Rise by 0.8% Amidst Global Economic Challenges, Following a Strong 1.1% Expansion in Q1

2026-08-26 23:51; UTC

Market Cautiously Awaits Insights from Jackson Hole Symposium as Inflation Concerns and Fed Dissent Shape Economic Outlook.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

74.22% į viršų

12 mėnesių prognozė

Vidutinis 5 USD  74.22%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

2

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat